Literature DB >> 26234753

LRRK2 A419V variant is a risk factor for Parkinson's disease in Asian population.

Kai Li1, Bei-sha Tang2, Zhen-hua Liu1, Ji-feng Kang1, Yuan Zhang1, Lu Shen2, Nan Li3, Xin-xiang Yan3, Kun Xia4, Ji-feng Guo5.   

Abstract

Recently, LRRK2 A419V (rs34594498) was reported associating with Parkinson's disease (PD) in Asian population; yet the conclusion is still unobvious. We conducted a case-control study to determine the potential associations between A419V and PD in Chinese population. Five hundred PD patients and 574 health controls were genotyped. Our results showed, A419V has a significantly higher frequency among PD patients than the controls (p = 0.025, odds ratio [OR] = 2.57, 95% confidence interval [CI] [1.13-5.86]), especially in early-onset PD (p = 0.027, OR = 10.40, 95% CI [1.31-82.89]). And PD patients who carried A419V have a lower Minimum-Mental State Examination scores than PD patients who did not (p = 0.04). We also conducted a meta-analysis on A419V. In Asian population, A419V was detected at a significantly higher frequency among PD patients in contrast to controls: Z = 2.47, p = 0.01, OR = 2.11, 95% CI [1.17-3.82]. When only considering the Chinese population, the difference was more obvious with Z = 3.41, p = 0.0007, OR = 2.07, 95% CI [1.36-3.14]. The results suggest LRRK2 A419V appears to be a risk factor for PD in Asian, especially in early-onset patients. Finally, larger sample with centering on young or cognitive impairment PD patients in Asian would be preferable for further confirmation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A419V; Cognitive impairment; LRRK2; Parkinson's disease; rs34594498

Mesh:

Substances:

Year:  2015        PMID: 26234753     DOI: 10.1016/j.neurobiolaging.2015.07.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  A glimpse of the genetics of young-onset Parkinson's disease in Central Asia.

Authors:  Rauan Kaiyrzhanov; Akbota Aitkulova; Jana Vandrovcova; David Murphy; Nazira Zharkinbekova; Chingiz Shashkin; Vadim Akhmetzhanov; Gulnaz Kaishibayeva; Altynay Karimova; Zhanybek Myrzayev; Malgorzata Murray; Talgat Khaibullin; John Hardy; Henry Houlden
Journal:  Mol Genet Genomic Med       Date:  2021-04-05       Impact factor: 2.473

Review 2.  Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.

Authors:  TaeHee Kim; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-01       Impact factor: 6.200

3.  Identification of Targets from LRRK2 Rescue Phenotypes.

Authors:  Joanne Toh; Ling Ling Chua; Patrick Ho; Edwin Sandanaraj; Carol Tang; Hongyan Wang; Eng King Tan
Journal:  Cells       Date:  2021-01-05       Impact factor: 6.600

4.  Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson's Disease.

Authors:  Marina V Shulskaya; Anelya Kh Alieva; Ivan N Vlasov; Vladimir V Zyrin; Ekaterina Yu Fedotova; Natalia Yu Abramycheva; Tatiana S Usenko; Andrei F Yakimovsky; Anton K Emelyanov; Sofya N Pchelina; Sergei N Illarioshkin; Petr A Slominsky; Maria I Shadrina
Journal:  Front Aging Neurosci       Date:  2018-05-15       Impact factor: 5.750

Review 5.  A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson's Disease.

Authors:  Yuan Zhang; Li Shu; Xun Zhou; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Parkinsons Dis       Date:  2018-09-27

6.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

7.  LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson's Disease Cohort from Kazakhstan.

Authors:  Rauan Kaiyrzhanov; Akbota Aitkulova; Chingiz Shashkin; Nazira Zharkinbekova; Mie Rizig; Elena Zholdybayeva; Zharkyn Jarmukhanov; Vadim Akhmetzhanov; Gulnaz Kaishibayeva; Talgat Khaibullin; Altynay Karimova; Serik Akshulakov; Askhat Bralov; Nurlan Kissamedenov; Zhanar Seidinova; Anjela Taskinbayeva; Aliya Muratbaikyzy; Henry Houlden
Journal:  Parkinsons Dis       Date:  2020-02-19

Review 8.  Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.

Authors:  Xinyao Liu; Weidong Le
Journal:  Front Aging Neurosci       Date:  2020-10-30       Impact factor: 5.750

9.  Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease.

Authors:  Ran Zheng; Chong-Yao Jin; Ying Chen; Yang Ruan; Ting Gao; Zhi-Hao Lin; Jia-Xian Dong; Ya-Ping Yan; Jun Tian; Jia-Li Pu; Bao-Rong Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.